相关实验视频
Updated: Jun 13, 2025

05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.0K
慢性阻塞性肺病死亡风险预测模型的开发和验证:使用概率图形建模的横截面研究
Tyler C Lovelace1,2, Min Hyung Ryu3, Minxue Jia1,2
1Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
EClinicalMedicine
|September 12, 2024
概括
一个新的VAPORED评分准确预测慢性阻塞性肺病 (COPD) 患者的死亡风险. 这种工具超越了现有的得分,帮助临床医生识别高风险个体,以更好地管理疾病.
科学领域:
- 肺部医学 肺部医学
- 生物统计学 生物统计学
- 基因组学就是基因组学.
背景情况:
- 慢性阻塞性肺病 (COPD) 是全球死亡的一个重要原因.
- 预测死亡风险对于有效的COPD管理至关重要.
- 有限的研究存在于具体影响COPD相关死亡率的因素.
研究的目的:
- 通过使用概率图形模型,识别直接影响全因和COPD特定死亡率的因素.
- 为COPD患者开发和验证一种新的死亡风险预测模型.
- 将新模型的性能与现有风险评分进行比较.
主要方法:
- 来自COPDGene和ECLIPSE队列的多模式数据 (临床,成像,遗传) 的回顾性分析.
- 应用概率图形模型来识别死亡率预测因素.
- 开发VAPORED (用于预测COPD结果和事件风险的评估变量) 评分,使用受罚的考克斯回归.
- 使用一致性,CPE和AUC指标对BODE和ADO指数进行VAPORED的验证.
主要成果:
- 图形模型确定了所有原因和COPD特定死亡率的关键预测因素.
- VAPORED评分,包括FEV1/FVC,FVC%预测,年龄,肺炎史,氧气和,6分钟步行距离和呼吸障碍,显示出卓越的表现.
- 在多个评估指标中,VAPORED在预测ECLIPSE队列3年全因死亡率方面显著优于ADO,BODE和更新的BODE.
- 其他因素,如互联网接入,CD4 T细胞和血小板,在第二阶段数据中与较低的死亡风险有关.
结论:
- 与现有评分相比,VAPORED评分可以更准确地预测COPD患者的死亡风险.
- 这种工具可以改善高风险个体的识别,促进个性化的疾病管理策略.
- 该研究还提出了影响COPD死亡率的生物和社会因素的假设.
相关概念视频
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K

